276 related articles for article (PubMed ID: 18658135)
21. Heterogeneous nuclear ribonucleoprotein E3 modestly activates splicing of tau exon 10 via its proximal downstream intron, a hotspot for frontotemporal dementia mutations.
Wang Y; Gao L; Tse SW; Andreadis A
Gene; 2010 Feb; 451(1-2):23-31. PubMed ID: 19914360
[TBL] [Abstract][Full Text] [Related]
22. A novel DYRK1A (dual specificity tyrosine phosphorylation-regulated kinase 1A) inhibitor for the treatment of Alzheimer's disease: effect on Tau and amyloid pathologies in vitro.
Coutadeur S; Benyamine H; Delalonde L; de Oliveira C; Leblond B; Foucourt A; Besson T; Casagrande AS; Taverne T; Girard A; Pando MP; Désiré L
J Neurochem; 2015 May; 133(3):440-51. PubMed ID: 25556849
[TBL] [Abstract][Full Text] [Related]
23. The alternative splicing of tau exon 10 and its regulatory proteins CLK2 and TRA2-BETA1 changes in sporadic Alzheimer's disease.
Glatz DC; Rujescu D; Tang Y; Berendt FJ; Hartmann AM; Faltraco F; Rosenberg C; Hulette C; Jellinger K; Hampel H; Riederer P; Möller HJ; Andreadis A; Henkel K; Stamm S
J Neurochem; 2006 Feb; 96(3):635-44. PubMed ID: 16371011
[TBL] [Abstract][Full Text] [Related]
24. Tau exon 10 alternative splicing and tauopathies.
Liu F; Gong CX
Mol Neurodegener; 2008 Jul; 3():8. PubMed ID: 18616804
[TBL] [Abstract][Full Text] [Related]
25. Truncated Dyrk1A aggravates neuronal apoptosis by inhibiting ASF-mediated Bcl-x exon 2b inclusion.
Zhang S; Zhong J; Xu L; Wu Y; Xu J; Shi J; Gu Z; Li X; Jin N
CNS Neurosci Ther; 2024 Apr; 30(4):e14493. PubMed ID: 37864462
[TBL] [Abstract][Full Text] [Related]
26. Cyclic AMP-dependent protein kinase regulates 9G8-mediated alternative splicing of tau exon 10.
Gu J; Shi J; Wu S; Jin N; Qian W; Zhou J; Iqbal IG; Iqbal K; Gong CX; Liu F
FEBS Lett; 2012 Jul; 586(16):2239-44. PubMed ID: 22677170
[TBL] [Abstract][Full Text] [Related]
27. Regulation of RCAN1 protein activity by Dyrk1A protein-mediated phosphorylation.
Jung MS; Park JH; Ryu YS; Choi SH; Yoon SH; Kwen MY; Oh JY; Song WJ; Chung SH
J Biol Chem; 2011 Nov; 286(46):40401-12. PubMed ID: 21965663
[TBL] [Abstract][Full Text] [Related]
28. DYRK1A-dosage imbalance perturbs NRSF/REST levels, deregulating pluripotency and embryonic stem cell fate in Down syndrome.
Canzonetta C; Mulligan C; Deutsch S; Ruf S; O'Doherty A; Lyle R; Borel C; Lin-Marq N; Delom F; Groet J; Schnappauf F; De Vita S; Averill S; Priestley JV; Martin JE; Shipley J; Denyer G; Epstein CJ; Fillat C; Estivill X; Tybulewicz VL; Fisher EM; Antonarakis SE; Nizetic D
Am J Hum Genet; 2008 Sep; 83(3):388-400. PubMed ID: 18771760
[TBL] [Abstract][Full Text] [Related]
29. microRNAs expression correlates with levels of APP, DYRK1A, hyperphosphorylated Tau and BDNF in the hippocampus of a mouse model for Down syndrome during ageing.
Chaves JCS; Machado FT; Almeida MF; Bacovsky TB; Ferrari MFR
Neurosci Lett; 2020 Jan; 714():134541. PubMed ID: 31605772
[TBL] [Abstract][Full Text] [Related]
30. Role of tau protein in neuronal damage in Alzheimer's disease and Down syndrome.
Cárdenas AM; Ardiles AO; Barraza N; Baéz-Matus X; Caviedes P
Arch Med Res; 2012 Nov; 43(8):645-54. PubMed ID: 23142525
[TBL] [Abstract][Full Text] [Related]
31. Regulation of alternative splicing of tau exon 10.
Qian W; Liu F
Neurosci Bull; 2014 Apr; 30(2):367-77. PubMed ID: 24627328
[TBL] [Abstract][Full Text] [Related]
32. The DYRK1A gene, encoded in chromosome 21 Down syndrome critical region, bridges between beta-amyloid production and tau phosphorylation in Alzheimer disease.
Kimura R; Kamino K; Yamamoto M; Nuripa A; Kida T; Kazui H; Hashimoto R; Tanaka T; Kudo T; Yamagata H; Tabara Y; Miki T; Akatsu H; Kosaka K; Funakoshi E; Nishitomi K; Sakaguchi G; Kato A; Hattori H; Uema T; Takeda M
Hum Mol Genet; 2007 Jan; 16(1):15-23. PubMed ID: 17135279
[TBL] [Abstract][Full Text] [Related]
33. Dyrk1A phosphorylates p53 and inhibits proliferation of embryonic neuronal cells.
Park J; Oh Y; Yoo L; Jung MS; Song WJ; Lee SH; Seo H; Chung KC
J Biol Chem; 2010 Oct; 285(41):31895-906. PubMed ID: 20696760
[TBL] [Abstract][Full Text] [Related]
34. SIRT1 Deacetylates SC35 and Suppresses Its Function in Tau Exon 10 Inclusion.
Yin X; Jiang X; Wang J; Qian S; Liu F; Qian W
J Alzheimers Dis; 2018; 61(2):561-570. PubMed ID: 29226865
[TBL] [Abstract][Full Text] [Related]
35. Dyrk1A-ASF-CaMKIIδ Signaling Is Involved in Valsartan Inhibition of Cardiac Hypertrophy in Renovascular Hypertensive Rats.
Yao J; Qin X; Zhu J; Sheng H
Cardiology; 2016; 133(3):198-204. PubMed ID: 26619200
[TBL] [Abstract][Full Text] [Related]
36. Neprilysin Is Suppressed by Dual-Specificity Tyrosine-Phosphorylation Regulated Kinase 1A (DYRK1A) in Down-Syndrome-Derived Fibroblasts.
Kawakubo T; Mori R; Shirotani K; Iwata N; Asai M
Biol Pharm Bull; 2017; 40(3):327-333. PubMed ID: 28250274
[TBL] [Abstract][Full Text] [Related]
37. Trisomy-driven overexpression of DYRK1A kinase in the brain of subjects with Down syndrome.
Dowjat WK; Adayev T; Kuchna I; Nowicki K; Palminiello S; Hwang YW; Wegiel J
Neurosci Lett; 2007 Feb; 413(1):77-81. PubMed ID: 17145134
[TBL] [Abstract][Full Text] [Related]
38. Dual-specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A) enhances tau expression.
Qian W; Jin N; Shi J; Yin X; Jin X; Wang S; Cao M; Iqbal K; Gong CX; Liu F
J Alzheimers Dis; 2013; 37(3):529-38. PubMed ID: 23948904
[TBL] [Abstract][Full Text] [Related]
39. Involvement of the dual-specificity tyrosine phosphorylation-regulated kinase 1A-alternative splicing factor-calcium/calmodulin-dependent protein kinase IIδ signaling pathway in myocardial infarction-induced heart failure of rats.
He J; Yao J; Sheng H; Zhu J
J Card Fail; 2015 Sep; 21(9):751-60. PubMed ID: 26067684
[TBL] [Abstract][Full Text] [Related]
40. Understanding the Multifaceted Role of Human Down Syndrome Kinase DYRK1A.
Kay LJ; Smulders-Srinivasan TK; Soundararajan M
Adv Protein Chem Struct Biol; 2016; 105():127-71. PubMed ID: 27567487
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
